SalioGen Therapeutics
SalioGen Therapeutics has $135.0M in recorded funding across 2 rounds.
- Website
- saliogen.com
- Total Funding
- $135.0M
- Last Round
- $115.0M Series BJan 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
SalioGen Therapeutics is a Biotech company. It has raised $135.0M in total across 2 rounds, most recently a $115.0M Series B round in Jan 2022. Investors include GordonMD Global Investments, EPIQ Capital Group and PBM Capital.
Funding History
Jan 2022
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/saliogen-therapeutics"><img src="https://indexed.vc/api/badge/company/saliogen-therapeutics" alt="SalioGen Therapeutics on Indexed.vc" width="260" height="76" /></a>